BRIEF published on 10/14/2024 at 18:05, 1 month 6 days ago Purchase of own shares by Jacques Bogart in September 2024 Stock Transactions Jacques Bogart Investment September 2024 Market Purchase LCL Deposit Account
BRIEF published on 10/14/2024 at 17:55, 1 month 6 days ago Monthly information on the voting rights of JACQUES BOGART Financial Information Share Capital Voting Rights Actions Jacques Bogart
BRIEF published on 09/26/2024 at 18:05, 1 month 24 days ago Jacques Bogart Announces H1 2024 Results: EBITDA Up by 13.9% EBITDA Net Loss Turnover Jacques Bogart H1 2024
PRESS RELEASE published on 09/26/2024 at 18:00, 1 month 24 days ago H1 2024 RESULTS BOGART reports H1 2024 results with turnover at €134.0 million (-2.6%) and EBITDA growth of 13.9%, driven by reorganisation and strong performance in Bogart Beauty Retail EBITDA Turnover Results BOGART H1 2024
BRIEF published on 09/16/2024 at 18:05, 2 months 4 days ago Declaration of Transactions in Own Shares Carried Out by Jacques Bogart Transactions Own Shares Purchase Jacques Bogart Walk
BRIEF published on 09/13/2024 at 19:35, 2 months 7 days ago Jacques Bogart: Monthly information on voting rights Voting Rights Capital Actions AMF JBOG
BRIEF published on 07/25/2024 at 18:05, 3 months 26 days ago Turnover for the first half of 2024: EUR 133.5 million Retail Cosmetics Turnover Fragrances BOGART
PRESS RELEASE published on 07/25/2024 at 18:00, 3 months 26 days ago H1 2024 turnover: EUR 133.5 million Bogart's H1 2024 revenues reached €139.3m, with Fragrances & Cosmetics at €26.4m (-5.0%) and Beauty Retail at €107.1m (-2.5%). Strategy includes new brand launches and margin expansion Revenues Strategy Cosmetics Fragrances BOGART
BRIEF published on 07/10/2024 at 18:20, 4 months 10 days ago Transactions on Jacques Bogart's own shares in June 2024 Own Shares Stock Transactions Jacques Bogart June 2024
BRIEF published on 07/10/2024 at 18:05, 4 months 10 days ago Monthly Information Relating to the Voting Rights of JACQUES BOGART Capital Monthly Information AMF Jacques Bogart Right To Vote
Published on 11/21/2024 at 10:03, 53 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 56 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 56 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 21 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 31 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 26 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 51 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 53 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 56 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 56 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 3 hours 58 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 36 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 11 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 11 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
